Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Terminated Initiated Aug 25, 2020 (6 years ago)

Nature-Throid

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

CGMP Deviations: manufactured under the same conditions as those found to be subpotent.

Cause type: Wrong potency / content

Sub- or super-potent product, or a failed content-uniformity / assay test. You may receive too little or too much active ingredient - a direct dosing risk. All wrong potency / content recalls.

What was recalled

Nature-Throid, Thyroid USP [liothyronine (T3) 18 mcg and levothyroxine (T4) 76 mcg], 2 Grain (130 mg) Tablets, packaged in a) 30-count bottles, NDC 64727-3308-4; b) 60-count bottles, NDC 64727-3308-5; c) 90-count bottles, NDC 64727-3308-6; d) 100-count bottles, NDC 64727-3308-1; and e) 1,000-count bottles, NDC 64727-3308-2; Rx only, Manufactured by: RLC Labs Phoenix, AZ 85034.

Affected NDCs 64727-3308-01 64727-3308-02 64727-3308-04 64727-3308-05 64727-3308-06

Compare with the code on your package — it is the most precise check available.

Drug: Levothyroxine Category: Thyroid Medication

Recalling firm
RLC Labs Inc.
NDC code
64727-3308-4
Origin
AZ, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-1602-2020 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other Levothyroxine recalls

See all

Other recalls by RLC Labs Inc.

All 2020 recalls
Class I · High risk

Nature Throid

Subpotent Drug: FDA analysis found product to be subpotent

Terminated Wrong potency / content RLC Labs Inc. NDC 64727-3305-4 D-1619-2020
Class I · High risk

Nature Throid

Subpotent Drug: FDA analysis found product to be subpotent

Terminated Wrong potency / content RLC Labs Inc. NDC 64727-3308-4 D-1618-2020
Class I · High risk

Nature Throid

Subpotent Drug: FDA analysis found product to be subpotent

Terminated Wrong potency / content RLC Labs Inc. NDC 64727-3303-1 D-1617-2020
Class I · High risk

Nature Throid

Subpotent Drug: FDA analysis found product to be subpotent

Terminated Wrong potency / content RLC Labs Inc. NDC 64727-3302-1 D-1616-2020